Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.

  • Picture of a pill

    New Levodopa Pill Hits Pharmacy Shelves

    A new, easy-to-break levodopa pill aims to allow smaller, more precise doses for potentially better symptom control.

  • Study on Rate of Dopamine Loss Emphasizes Need for Biomarkers

    What We Fund Highlight: Replacing Dopamine with Stem Cells and Brain Cells

  • Patients and Doctor

    News In Context: Arthritis Drugs Linked to Lower Risk of Parkinson’s

    Recent research links, among people with rheumatoid arthritis, two arthritis medications to a lower risk of Parkinson’s.

  • Researcher in lab holding test tube

    MJFF Survey Results: People with Parkinson’s Share Experiences with Cannabis

    Many use cannabis, including marijuana, for Parkinson’s. These “real world” experiences can help guide doctors’ care and help researchers design clinical trials.

  • Hands typing on a keyboard

    Answering Your Questions from Our “PPMI: The Study that Could Change Everything” Webinar

    Our expert panelists addressed several questions around the Foundation’s landmark Parkinson’s Progression Markers Initiative study.

  • Three people talking at a clinic

    Research Roundup: Five Parkinson’s Studies Need Volunteers

    In this research roundup blog, we share five Parkinson’s studies in need of volunteers.

Close-up portrait

Join the Study that Could Change Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.